603127-基本财务实时评分详情
昭衍新药603127基本财务实时评分详情
更新时间:2020-11-28 00:00:01
股票代码
603127
当期评分
股票名称
昭衍新药
报告日期2016-12-312017-12-312018-12-312019-12-312020-09-302020-09-30
每股经营现金流(¥)--1.46711.53120.91570.9883
销售净利润率(%)21.377825.373926.464727.872618.5597
销售毛利率(%)49.572455.209952.239752.003449.0297
净资产收益率(%)19.8913.7116.6321.5812.19
营业增长率(%)17.037124.595735.687656.404781.2323
净利润增长率(%)5.1247.886141.520464.725354.2738
每股收益(%)0.841.120.941.110.52
现金流量比率(%)47.111338.538743.0330.672131.5666
三项费用比重(%)27.11727.295619.595316.521323.9763
每股净资产(¥)4.246.81465.66395.11094.2806
流动比率(%)0.95611.91861.6861.32691.2646
速动比率(%)0.70091.62241.4060.91170.7802
现金比率(%)52.6133129.938636.338136.650636.6506
总资产利润率(%)9.58129.941410.391213.92697.2855
主营利润比重%196.4732178.0586167.0269161.4933232.6377
应收账款(万元)1,731.782,641.023,874.1410,636.85
应收票据(万元)189.96300.29605.59191.14
预付款项(万元)711.73499.62887.48715.68
存货(万元)6,437.509,223.6611,455.9920,048.13
在建工程(万元)5,709.834,916.427,958.623,530.65
应付款项(万元)1,946.131,293.042,013.054,369.83
长期借款(万元)------917.50
未分配利润(万元)12,853.2520,276.6028,215.2841,014.13
商誉(万元)------13,396.20
流动资产(万元)35,591.6134,342.5045,150.9977,717.30
流动负债(万元)25,221.5931,139.1140,919.2448,282.43
昭衍新药603127评分结果
63.64分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006